Posted on 12/10/2020 4:52:20 PM PST by RummyChick
The Australian government has terminated its agreement with Australian biotech company CSL Limited to supply 51m doses of a Covid-19 vaccine being developed by the University of Queensland, after vaccine trial participants returned false positive test results for HIV.
Australia had hoped the protein vaccine would be available by mid-2021. Phase one clinical trials in humans began in July in Brisbane, with phase two and three clinical trials due to commence in December. It is one of four vaccines secured by the Australian government
(Excerpt) Read more at theguardian.com ...
Sydney herald has the story but you cant post it here
The “protein” vaccine. Huh.
May not have been false-positives.
Might be that the vaccine gave them HIV.
I’ll bet it’s not ‘false’ positives for HIV since we already know vaccines have the HIV strain in them.
So the early report with this thing having a chunk of HIV in it was true unlike what Pravda broadcasts. What could possibly go wrong with putting some of that in a vax?
I’ll stick to EVMS/Front Line protocols with Ivermectin.
Rule Number One: No poofters!
Yes, I read the Sydney Morning Herald’s article on this vaccine. It was, IMHO, poorly thought out and was destined to fail. Glad it did. Looking forward to the Well-thought out Moderna vaccine which should be approved in about a week.
I’ll bet this will raise havoc with blood donation.
“Do you have HIV?, etc.”
Well, we found this in your blood.
And what else might the different vaccines do to the blood supply?
I’ll bet it’s not ‘false’ positives for HIV since we already know vaccines have the HIV strain in them.
~~~~~~~~~~~~~~~~~~~~~~~
What other vaccines have the HIV strain in them?
according to Judy Miskovitz, and others, pretty much all of them.
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.